Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
33 participants
OBSERVATIONAL
2012-06-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
NCT02168764
Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache
NCT01540799
Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache
NCT01255813
Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache
NCT01677026
Pathway CH S&E Registry
NCT02440776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pathway CH-1 Subjects
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has completed the Pathway CH-1 Open Label Final office visit and remains implanted with an ATI Neurostimulator.
* Subject has the ability to read, comprehend and to reliably record information as required by the Protocol.
* Subject is able to provide written informed consent prior to participation in the study.
Exclusion Criteria
* Subject is not suitable for the study for any reason in the judgment of the Investigator.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Autonomic Technologies, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Schoenen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Citadelle Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Headache Research Unit. University Department of Neurology, Citadelle Hospital
Liège, , Belgium
Danish Headache Center & Department of Neurology, Glostrup Hospital, University of Copenhagen
Glostrup, Copenhagen, Denmark, Denmark
Servicio de Neurologia, Hospital Clinico Universitario
Valencia, Spain, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.